Mannatech (NASDAQ:MTEX) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research note released on Sunday. The brokerage issued a buy rating on the stock.

Mannatech Stock Performance

Shares of MTEX opened at $7.62 on Friday. The stock has a 50 day moving average price of $7.31 and a 200 day moving average price of $7.77. The company has a quick ratio of 0.62, a current ratio of 1.17 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $14.33 million, a price-to-earnings ratio of -8.56 and a beta of 1.17. Mannatech has a 52-week low of $6.75 and a 52-week high of $11.80.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share (EPS) for the quarter. The business had revenue of $27.74 million during the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%.

Insider Buying and Selling at Mannatech

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the sale, the director now owns 54,721 shares in the company, valued at $424,087.75. The sale was disclosed in a document filed with the SEC, which is available through this link. 41.50% of the stock is owned by company insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.